- Home
- MBIO vs CHNR Comparison
MBIO vs CHNR Comparison
Compare MBIO & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MBIO | CHNR |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 5.3M |
| IPO Year | 2023 | 1996 |
Fundamental Metrics
Financial Performance| Metric | MBIO | CHNR |
|---|---|---|
| Price | $0.60 | $3.91 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 34.2K | 22.9K |
| Earning Date | 05-13-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 98.99 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.53 | $0.50 |
| 52 Week High | $7.00 | $57.47 |
Technical Indicators
Market Signals| Indicator | MBIO | CHNR |
|---|---|---|
| Relative Strength Index (RSI) | 25.57 | 50.49 |
| Support Level | $0.53 | $4.09 |
| Resistance Level | $0.80 | $4.65 |
| Average True Range (ATR) | 0.03 | 0.34 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 2.74 | 19.52 |
Price Performance
Historical ComparisonAbout MBIO Mustang Bio Inc.
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is engaged in exploration for lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and exploration of attractive opportunities in other sectors. The company has a single operating segment: exploration and mining.